Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB133139

IRX4 Rabbit anti-Human, DyLight 405, Polyclonal, Novus Biologicals™
SDP

Catalog No. NB133139 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB133139 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB133139 Supplier Novus Biologicals Supplier No. NBP306171V

Description

Rabbit Polyclonal Antibody

IRX4 Polyclonal specifically detects IRX4 in Human samples. It is validated for Western Blot, Immunocytochemistry/Immunofluorescence.

Specifications

Antigen IRX4
Applications Western Blot, Immunofluorescence
Classification Polyclonal
Conjugate DyLight 405
Dilution Western Blot, Immunocytochemistry/Immunofluorescence
Formulation 50mM Sodium Borate
Gene Alias iroquois homeobox 4, Iroquois homeobox protein 4Homeodomain protein IRXA3, iroquois-class homeodomain protein IRX-4, IRXA3, MGC131996
Host Species Rabbit
Immunogen Produced in rabbits immunized with a synthetic peptide corresponding to the center region of the Human IRX4.
Purification Method Antigen and protein A Affinity-purified
Quantity 0.1 mL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 50805
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.